Literature DB >> 30074220

Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study.

Yin-Mei Chen1, Qian-Rong Qi1, Qing-Zhen Xie2, Yi-Fan Yang1, Yi Xia1, Xiao-Dan Zhou1.   

Abstract

This study aimed to explore the outcomes of progestin-primed ovarian stimulation protocol (PPOS) in aged infertile women who failed to get pregnant in the first IVF/ICSI-ET cycles with GnRH-a long protocol. A self-controlled study was conducted to retrospectively investigate the clinical outcomes of 104 aged infertile patients who didn't get pregnant in the first IVF/ICSI-ET treatment by stimulating with GnRH-a long protocol (non-PPOS group), and underwent PPOS protocol (PPOS group) in the second cycle between January 2016 and December 2016 in the Center for Reproductive Medicine, Renmin Hospital of Wuhan University. The primary outcomes included clinical pregnancy rate of frozen-thawed embryos transfer (FET) in PPOS group, and good-quality embryo rate in both groups. The secondary outcomes were fertilization rate, egg utilization rate and cycle cancellation rate. The results showed that there were no significant differences in basal follicle stimulating hormone (bFSH), antral follicle count (AFC), duration and total dosage of gonadotropin (Gn), number of oocytes retrieved, intracytoplasmic sperm injection (ICSI) rate, fertilization rate, and cycle cancellation rate between the two groups (P>0.05). However, the oocyte utilization rate and good-quality embryo rate in PPOS group were significantly higher than those in non-PPOS group (P<0.05). By the end of April 2017,62 FET cycles were conducted in PPOS group. The clinical pregnancy rate and embryo implantation rate were 22.58% and 12.70%, respectively. In conclusion, PPOS protocol may provide better clinical outcomes by improving the oocyte utilization rate and good-quality embryo rate for aged infertile patients who failed to get pregnant in the first IVF/ICSI-ET cycles.

Entities:  

Keywords:  advanced age; in vitro fertilization and embryo transfer; progestin-primed ovarian stimulation

Mesh:

Substances:

Year:  2018        PMID: 30074220     DOI: 10.1007/s11596-018-1908-z

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  31 in total

Review 1.  Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.

Authors:  S Daya
Journal:  Cochrane Database Syst Rev       Date:  2000

2.  Testing and interpreting measures of ovarian reserve: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2015-01-10       Impact factor: 7.329

3.  Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.

Authors:  Hong Chen; Yun Wang; Qifeng Lyu; Ai Ai; Yonglun Fu; Hui Tian; Renfei Cai; Qingqing Hong; Qiuju Chen; Zeev Shoham; Yanping Kuang
Journal:  Fertil Steril       Date:  2015-03-23       Impact factor: 7.329

Review 4.  Evolutionary defined role of the mitochondrial DNA in fertility, disease and ageing.

Authors:  Auke B C Otten; Hubert J M Smeets
Journal:  Hum Reprod Update       Date:  2015-05-14       Impact factor: 15.610

5.  Progesterone can block the preovulatory gonadotropin-releasing hormone/luteinising hormone surge in the ewe by a direct inhibitory action on oestradiol-responsive cells within the hypothalamus.

Authors:  T A Richter; J E Robinson; J M Lozano; N P Evans
Journal:  J Neuroendocrinol       Date:  2005-03       Impact factor: 3.627

6.  Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above.

Authors:  Gamal Serour; Ragaa Mansour; Ahmed Serour; Mona Aboulghar; Yahia Amin; Omnia Kamal; Hesham Al-Inany; Mohamed Aboulghar
Journal:  Fertil Steril       Date:  2009-11-06       Impact factor: 7.329

7.  Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study.

Authors:  Ningling Wang; Yun Wang; Qiuju Chen; Jing Dong; Hui Tian; Yonglun Fu; Ai Ai; Qifeng Lyu; Yanping Kuang
Journal:  Clin Endocrinol (Oxf)       Date:  2015-12-21       Impact factor: 3.478

8.  Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.

Authors:  Yanping Kuang; Qingqing Hong; Qiuju Chen; Qifeng Lyu; Ai Ai; Yonglun Fu; Zeev Shoham
Journal:  Fertil Steril       Date:  2013-10-23       Impact factor: 7.329

9.  Progesterone promotes oocyte maturation, but not ovulation, in nonhuman primate follicles without a gonadotropin surge.

Authors:  Sherri M Borman; Charles L Chaffin; Kristine M Schwinof; Richard L Stouffer; Mary B Zelinski-Wooten
Journal:  Biol Reprod       Date:  2004-02-25       Impact factor: 4.285

10.  Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.

Authors:  Yun Wang; Qiuju Chen; NingLing Wang; Hong Chen; Qifeng Lyu; Yanping Kuang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more
  1 in total

1.  The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation

Authors:  Gülşen Doğan Durdağ; Gizem Bektaş; Esengül Türkyılmaz; Halime Göktepe; Meltem Sönmezer; Yavuz Emre Şükür; Batuhan Özmen; Cem Atabekoğlu; Bülent Berker; Ruşen Aytaç; Murat Sönmezer
Journal:  J Turk Ger Gynecol Assoc       Date:  2021-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.